23andMe — 2015 Investments

1 investments dated 2015 · listed companies and verified rows first · show all

Twist Biosciencetwistbioscience.com in 𝕏NASDAQ: TWSTSeries C · Jun 2015 · $37M

Twist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals.

BiotechDeep TechSemiconductorsSouth San Francisco, US

William Charles Banyai(Executive Officer, Director, Promoter)Bill James Peck(Executive Officer, Promoter)Emily Leproust(Founder)inEmily Leproust, PhD(CEO and Co-Founder of Twist)Patrick Finn(President and Chief Operating Officer)in Adam Laponis(Chief Financial Officer)in

Co-investors+ND Capital 3E Bioventures Capital ARCH Venture Partners Asset Management Company ATEL Ventures Bay City Capital +10 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.